查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948361

2026年全球器官移植诊断市场报告

Transplant Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，移植诊断市场发展迅速，预计将从2025年的20.7亿美元成长到2026年的22.5亿美元，复合年增长率达8.5%。过去几年的成长可归因于多种因素，例如器官移植手术数量的增加、组织配对技术的进步、免疫遗传疾病盛行率的上升、移植中心的扩张以及政府对器官捐赠计画的资助。

预计未来几年，移植诊断市场将维持强劲成长，2030年市场规模将达到29.6亿美元，复合年增长率（CAGR）为7.1%。预测期内的成长主要归功于人工智慧和机器学习在检测领域的应用、次世代定序（NGS）技术的普及、个人化免疫疗法的扩展、云端诊断筛检的兴起以及全球器官捐赠意识的不断提高。预测期内的关键趋势包括快速组织分型、人工智慧辅助的供受者配对、分子诊断技术的整合、高通量筛选技术以及云端移植资料管理。

慢性病盛行率的不断上升正在推动移植诊断市场的未来扩张。慢性病是指通常进展缓慢的长期健康状况，例如糖尿病、心臟病和关节炎，这些疾病往往需要持续的医疗监测和生活方式的改变来控制症状并避免併发症。慢性病的增加很大程度上与不健康的生活方式习惯有关，例如营养不良、缺乏运动和吸烟，这些都会增加心血管疾病、糖尿病和肥胖的风险。移植诊断在慢性病治疗中发挥着至关重要的作用，它能够准确监测器官功能并早期发现移植相关併发症。这些诊断工具透过支持及时的临床决策、个人化的治疗策略和提高器官的长期存活率来改善患者的预后。例如，根据英国政府机构国家医疗服务体系（NHS）的数据，截至2024年6月，在全科医生（GP）註册的患者中，有3,615,330人在2023年被诊断出患有非糖尿病性高血糖症，比2022年增加了18%。因此，慢性病盛行率的上升正在促进移植诊断技术的日益普及。

为了扩大在移植诊断市场的份额，主要企业正致力于推出先进的移植诊断服务。这些服务利用创新工具和技术，提高移植前后检测的准确性和效率。例如，总部位于美国的医疗检测公司Quest Diagnostics于2023年3月推出了“Quest高级专业移植服务”，提供超过170种专业的移植和传染病检查。这些服务包括：在电子健康记录中分析检测结果、提供24小时临床咨询支援、提供病患教育资料以及快速检测服务（部分结果可在8至24小时内取得）。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球器官移植诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 快速组织分型
    • 基于人工智慧的供受者匹配
    • 分子诊断整合
    • 高通量筛检技术
    • 基于云端的移植资料管理

第五章 终端用户产业市场分析

  • 医院
  • 移植中心
  • 研究所
  • 商业诊断服务提供者
  • 学术机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球器官移植诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球器官移植诊断市场规模、比较及成长率分析
  • 全球器官移植诊断市场表现：规模与成长，2020-2025年
  • 全球器官移植诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球总潜在市场（TAM）

第九章 市场细分

  • 按类型
  • 试剂和耗材、设备、软体和服务
  • 按移植类型
  • 固态器官，干细胞
  • 管风琴
  • 肾臟、肝臟、心臟、肺臟、胰腺
  • 透过技术
  • 非分子检测、分子检测
  • 最终用户
  • 医院和移植中心、研究机构和移植中心、商业服务供应商
  • 按类型细分：试剂和耗材
  • PCR试剂、抗体和抗原、检体采集试剂盒、对照材料
  • 按类型细分：设备
  • 流式细胞仪、PCR仪、定序仪、发光仪
  • 按类型细分：软体和服务
  • 数据分析软体、实验室资讯管理系统（LIMS）、咨询服务、技术支援与维护服务

第十章 区域与国家分析

  • 全球器官移植诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球器官移植诊断市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 器官移植诊断市场：竞争格局与市场份额，2024 年
  • 器官移植诊断市场：公司估值矩阵
  • 器官移植诊断市场：公司概况
    • F. Hoffmann La-Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories Inc.
    • Becton-Dickinson and Company
    • Hologic Inc.

第37章：其他领先和创新企业

  • Illumina Inc., BioMerieus SA, Biomerieux SA, Grafton Companies, Bio-Rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen NV, Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年器官移植诊断市场：提供新机会的国家
  • 2030年器官移植诊断市场：新兴细分市场机会
  • 2030年器官移植诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MTDIA03_G26Q1

Transplant diagnostics refer to tests performed before organ or tissue transplantation. They primarily focus on histocompatibility and immunogenetics to evaluate compatibility between donor and recipient, particularly in organ transplants and hematopoietic stem cell transplants.

The main product categories in the transplant diagnostics market include reagents and consumables, instruments, and software and services. Transplant diagnostic instruments are designed to enhance the speed and accuracy of transplant-related testing. The technologies include non-molecular assays and molecular assays used for transplantation of organs such as the kidney, liver, heart, lung, and pancreas. The transplant types include solid organ and stem cell transplants, and these solutions are used by end users such as hospitals and transplant centers, research laboratories, and commercial service providers.

Tariffs are impacting the transplant diagnostics market by increasing costs for imported reagents, molecular assay kits, and sequencing instruments. Hospitals and transplant centers in regions like North America and Europe are most impacted, particularly for high-end molecular assays. While cost pressures have slowed some procurement, tariffs have also encouraged local manufacturing of reagents and instruments, stimulating regional market growth and innovation.

The transplant diagnostics market research report is one of a series of new reports from The Business Research Company that provides transplant diagnostics market statistics, including transplant diagnostics industry global market size, regional shares, competitors with a transplant diagnostics market share, detailed transplant diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the transplant diagnostics industry. This transplant diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transplant diagnostics market size has grown strongly in recent years. It will grow from $2.07 billion in 2025 to $2.25 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising organ transplantation procedures, advancements in histocompatibility testing, increasing prevalence of immunogenetic disorders, expansion of transplant centers, government funding for organ donation programs.

The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to integration of ai and machine learning in testing, adoption of next-generation sequencing (NGS), expansion of personalized immunotherapy, growth of cloud-based diagnostics platforms, increased global organ donation awareness. Major trends in the forecast period include rapid histocompatibility testing, ai-powered donor-recipient matching, molecular diagnostics integration, high-throughput screening techniques, cloud-based transplant data management.

The increasing prevalence of chronic diseases is increasingly supporting the expansion of the transplant diagnostics market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly, including diabetes, heart disease, and arthritis, and often require continuous medical supervision and lifestyle modifications to manage symptoms and avoid complications. The rise in chronic diseases is largely associated with unhealthy lifestyle patterns, such as poor nutrition, lack of physical activity, and smoking, which heighten the risk of cardiovascular disease, diabetes, and obesity. Transplant diagnostics play an essential role in chronic disease care by enabling accurate monitoring of organ function and early identification of transplant-related complications. These diagnostic tools improve patient outcomes by supporting timely clinical decisions, personalized treatment strategies, and enhanced long-term organ survival. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a GP were identified with non-diabetic hyperglycemia in 2023, representing an 18% increase from 2022. As a result, the growing prevalence of chronic diseases is contributing to increased adoption of transplant diagnostics.

Leading companies operating in the transplant diagnostics market are focused on introducing advanced transplant diagnostic services to expand their market presence. Advanced transplant diagnostic services use novel tools and technologies to improve the accuracy and efficiency of pre- and post-transplant testing. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory company, launched Quest Advanced Specialized Transplant Services, offering more than 170 specialized transplant and infectious disease tests. The service includes longitudinal test trend analysis in electronic medical records, 24-hour clinical consultation support, patient education materials, and expedited testing services, with some results available within 8 to 24 hours.

In October 2024, Werfen, S.A., a Spain-based supplier of specialized diagnostic instruments and reagents, acquired Omixon Biocomputing Ltd. for approximately $25 million. Through this acquisition, Werfen aims to strengthen and expand its transplant diagnostics portfolio in hospitals and clinical laboratories by incorporating Omixon's advanced next-generation sequencing and bioinformatics technologies. Omixon Biocomputing Ltd. is a Hungary-based molecular diagnostics company specializing in transplant diagnostic solutions.

Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomerieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The transplant diagnostics market includes revenues earned by entities by PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transplant Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses transplant diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transplant diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transplant diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Reagent And Consumables; Instrument; Software And Services
  • 2) By Transplant Type: Solid Organ; Stem Cell
  • 3) By Organ: Kidney; Liver; Heart; Lung; Pancreas
  • 4) By Technology: Non Molecular Assay; Molecular Assay
  • 5) By End User: Hospitals And Transplant Centers; Research Laboratories AndTransplant Centers; Commercial Service Providers
  • Subsegments:
  • 1) By Reagent And Consumables: PCR Reagents; Antibodies And Antigens; Sample Collection Kits; Control Materials
  • 2) By Instrument: Flow Cytometers; PCR Machines; Sequencers; Luminometers
  • 3) By Software And Services: Data Analysis Software; Laboratory Information Management Systems (LIMS); Consulting Services; Technical Support And Maintenance Services
  • Companies Mentioned: F. Hoffmann La-Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Becton-Dickinson and Company; Hologic Inc.; Illumina Inc.; BioMerieus S.A; Biomerieux SA; Grafton Companies; Bio-rad Laboratories Inc.; Sigma-Aldrich Corporation; Qiagen N.V.; Immucor Transplant Diagnostics Inc.; Immucor Inc.; Luminex Corporation; Affymetrix Inc.; CareDx Company; One Lambda Inc.; Eurobio Scientific Group; Gendx BV; Olerup SSp AB; Genome Diagnostics B.V.; Transplant Genomics Inc.; Omixon Ltd.; BAG Healthcare GmbH; Histogenetics Inc.; Linkage Biosciences lnc.; Gendrive plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Transplant Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Transplant Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Transplant Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Transplant Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rapid Histocompatibility Testing
    • 4.2.2 Ai-Powered Donor-Recipient Matching
    • 4.2.3 Molecular Diagnostics Integration
    • 4.2.4 High-Throughput Screening Techniques
    • 4.2.5 Cloud-Based Transplant Data Management

5. Transplant Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Transplant Centers
  • 5.3 Research Laboratories
  • 5.4 Commercial Diagnostic Service Providers
  • 5.5 Academic Institutions

6. Transplant Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Transplant Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Transplant Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Transplant Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Transplant Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Transplant Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Transplant Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Transplant Diagnostics Market Segmentation

  • 9.1. Global Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagent And Consumables, Instrument, Software And Services
  • 9.2. Global Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solid Organ, Stem Cell
  • 9.3. Global Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kidney, Liver, Heart, Lung, Pancreas
  • 9.4. Global Transplant Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non Molecular Assay, Molecular Assay
  • 9.5. Global Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Transplant Centers, Research Laboratories And Transplant Centers, Commercial Service Providers
  • 9.6. Global Transplant Diagnostics Market, Sub-Segmentation Of Reagent And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials
  • 9.7. Global Transplant Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Flow Cytometers, PCR Machines, Sequencers, Luminometers
  • 9.8. Global Transplant Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

10. Transplant Diagnostics Market Regional And Country Analysis

  • 10.1. Global Transplant Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Transplant Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Transplant Diagnostics Market

  • 11.1. Asia-Pacific Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Transplant Diagnostics Market

  • 12.1. China Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Transplant Diagnostics Market

  • 13.1. India Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Transplant Diagnostics Market

  • 14.1. Japan Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Transplant Diagnostics Market

  • 15.1. Australia Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Transplant Diagnostics Market

  • 16.1. Indonesia Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Transplant Diagnostics Market

  • 17.1. South Korea Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Transplant Diagnostics Market

  • 18.1. Taiwan Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Transplant Diagnostics Market

  • 19.1. South East Asia Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Transplant Diagnostics Market

  • 20.1. Western Europe Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Transplant Diagnostics Market

  • 21.1. UK Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Transplant Diagnostics Market

  • 22.1. Germany Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Transplant Diagnostics Market

  • 23.1. France Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Transplant Diagnostics Market

  • 24.1. Italy Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Transplant Diagnostics Market

  • 25.1. Spain Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Transplant Diagnostics Market

  • 26.1. Eastern Europe Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Transplant Diagnostics Market

  • 27.1. Russia Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Transplant Diagnostics Market

  • 28.1. North America Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Transplant Diagnostics Market

  • 29.1. USA Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Transplant Diagnostics Market

  • 30.1. Canada Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Transplant Diagnostics Market

  • 31.1. South America Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Transplant Diagnostics Market

  • 32.1. Brazil Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Transplant Diagnostics Market

  • 33.1. Middle East Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Transplant Diagnostics Market

  • 34.1. Africa Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Transplant Diagnostics Market Regulatory and Investment Landscape

36. Transplant Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Transplant Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Transplant Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Transplant Diagnostics Market Company Profiles
    • 36.3.1. F. Hoffmann La-Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton-Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Transplant Diagnostics Market Other Major And Innovative Companies

  • Illumina Inc., BioMerieus S.A, Biomerieux SA, Grafton Companies, Bio-Rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV

38. Global Transplant Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Transplant Diagnostics Market

40. Transplant Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Transplant Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Transplant Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Transplant Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer